Skip to main content
FinSpry Logo
FinSpry
BIOA logo
BIOA
(NASDAQ)
BioAge Labs, Inc.
$10.11-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

BioAge Labs (BIOA) Stock Price & Financial Analysis

BioAge Labs Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$9.55 - $10.13
52-Week High$25.96
52-Week Low$4.42
Open$9.55
Volume496.87K
Average Volume (3M)1.10M
Market Cap429.48M
Shares Outstanding42.48M
Price to Sales (P/S)41.63
Price to Book (P/B)1.13
EV/EBITDA-2.00
Revenue (TTM)10.32M
Net Income (TTM)-89.93M
Free Cash Flow (TTM)-88.63M
EPS (TTM)$-2.39
Profit Margin-871.75%
Operating Margin-985.93%
Return on Equity (ROE)-23.72%
Debt to Equity0.01
50-Day MA$18.33
200-Day MA$16.85
52-Week Change124.17%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About BioAge Labs

What is the current stock price for BIOA?

As of the latest trading session, BIOA stock trades at $10.11. The 52-week range is $4.42–$25.96, with a day range of $9.55–$10.13.

What is the P/E ratio for BIOA?

The P/E ratio (Price-to-Earnings) for BIOA is shown in the Key Statistics section. This valuation metric helps compare BioAge Labs, Inc. to industry peers.

Does BIOA pay dividends?

BioAge Labs does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BIOA?

Based on 3 analysts, the consensus for BIOA is Buy.

What is the market cap of BIOA?

BioAge Labs's market capitalization is $429.5M, classifying it as a small-cap company. BioAge Labs operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.